Concepedia

Carolin Temps

CT

5

Publications

134

Citations

5

H-Index

2018

Active since

Affiliations

Edinburgh Cancer Research(Current)

Carolin Temps is an author at Edinburgh Cancer Research specializing in medicine, drug resistance, and diabetes.

Top concepts

MedicineDiabetesDrug DesignCell BiologyPharmacologyOphthalmologyCell SignalingDrug DiscoveryDrug ResistancePharmacotherapy

Publications per year

2018–2021

5

Publications

5

A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability

Carolin Temps, Daniel Lietha, Emily R. Webb et al. · Cancer Research · 2021 · 50 citations · Full text

An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis

Harvey W. Smith, Alison Hirukawa, Virginie Sanguin‐Gendreau et al. · Nature Communications · 2019 · 41 citations · Full text

Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening

Samuel H. Myers, Carolin Temps, Douglas R. Houston et al. · Journal of Medicinal Chemistry · 2018 · 21 citations · Full text

Drug Target, Axl Kinase, Chemoprevention Strategy +20

The retinal tyrosine kinome of diabetic Akimba mice highlights potential for specific Src family kinase inhibition in retinal vascular disease

Jurgen Sergeys, Inge Van Hove, Tjing‐Tjing Hu et al. · Experimental Eye Research · 2020 · 12 citations · Full text

Ocular Disease, Signal Transduction, Retina +10

Synthesis and Characterization of a Click-Assembled 18-Atom Macrocycle That Displays Selective AXL Kinase Inhibitory Activity

Olga Cruz‐López, Carolin Temps, Beatrice Longo et al. · ACS Omega · 2019 · 10 citations · Full text

Rows per page

1–5 of 5